Comparative Evaluation of Osteoporosis Clinical Risk Assessment Tools in Postmenopausal Women Aged 50-64.
OST, despite its performance limitations, correlates best with the DXA measurements of young (50-64), postmenopausal osteoporotic women, a fact which may suggest its' potential role as a screening tool in this specific age group.
Authors
- Konstantinos Chlapoutakis (ORCID: https://orcid.org/0000-0002-2960-8488)
- Christos Baltas
- Αντώνιος Γαλανός
- Alexia Balanika (ORCID: https://orcid.org/0000-0003-0971-6390)
- Maria Froudaki
Institutions
- General Hospital of Athens G. Genimatas (GR)
Publication Details
- Journal
- PubMed
- Published
- 2024-12-01
- Citations
- 1
- Primary Topic
- Bone health and osteoporosis research
- Type
- article
- Field-Weighted Citation Impact
- 0.48